American Brain Tumor Association
Events Care & Support Donate Tumor Info About Us Home Home
 May 2012
 ABTA Tab

New ABTA Website
A redesigned ABTA website was launched in late April. Take a few minutes to visit the new www.abta.org and see the many ways in which the ABTA is working every day to advance the understanding and treatment of brain tumors. A mobile-friendly version will be available soon.

Download the Spring/Summer 2012 Headlines Newsletter
The Spring/Summer 2012 issue of Headlines is now available for download. This issue highlights ABTA-supported research for glioblastoma, challenges and changes in the caregiver role, the coast-to-coast expansion of the ABTA national events program, and much more. Click here to download the Spring/Summer 2012 Headlines. 

tab patient care
2012 ABTA Patient and Family Conference July 27-29
This year’s weekend conference features presentations from more than three dozen nationally renowned brain tumor experts speaking on a variety of brain tumor research and treatment topics. A Support Group Facilitator Training is also being held in conjunction with the event on Friday, July 27. Registration is open for both the conference and support group facilitator training at www.braintumorconference.org

Proton Therapy Webinar
“Understanding Proton Therapy,” the first in a series of free American Brain Tumor Association webinars, is scheduled for Friday, June 22, at 1:00 p.m., CST. Anita Mahajan, M.D., medical director of the MD Anderson Proton Therapy Center, is the featured presenter. The program includes an online Q&A session with Dr. Mahajan. To register, go to http://bit.ly/protontherapywebinar

Show Gray for Brain Tumor Awareness
To commemorate Brain Tumor Awareness Month in May, the ABTA is offering a discount on gray awareness wristbands. Use the promo code BTAWARE at www.abta.org to place your order. The ABTA is also providing daily brain tumor facts on Facebook (www.facebook.com/theABTA) and through Twitter (www.twitter.com/theABTA) throughout the month. Show your gray and increase awareness of the ABTA and our cause.  

Return to Sender
As we approach the year anniversary of our office relocation, the US Post Office has advised that we are also coming to the end of our mail forwarding service period. After June 1, mail sent to our former address will be returned to sender. If you haven’t already done so, please update your address book: American Brain Tumor Association, 8550 W. Bryn Mawr Ave., Suite 550, Chicago IL 60631.  

 

tab research newsUpdated Brain Tumor Incidence Report
According to the Central Brain Tumor Registry of the United States' (CBTRUS) recently released 2012 Statistical Report, meningioma is the most common primary brain tumor representing 35% of all reported brain tumors. The second most common primary tumor, at 16%, is glioblastoma. Of the 66,290 people who are diagnosed with a primary brain tumor this year, 4,200 are expected to be children. For an overview of brain tumor facts and statistics, click here. To access the complete CBTRUS report, click here

INTECH Offers Open Access to Online Book on Information and Treatment of Gliomas 
"Novel Therapeutic Concepts for Targeting Glioma" offers a comprehensive collection of current information and upcoming possibilities for the design of new therapies for glioma. The open access text, dated April 2012, was authored by an array of international experts ranging from cell biologists to oncologists and neurosurgeons. Edited by a 2003 ABTA research fellow, Faris Farassati, PhD, PharmD, the book addresses therapeutic strategies based on cell signaling, gene and drug therapies, and surgical methods. Click here to read and download (without charge) the book or selected chapters. 

Frameless Robotically-Targeted Stereotactic Brain Biopsy 
A study published in the May 2012 Journal of Neurosurgery reviews advances in brain tumor biopsies using frameless stereotactic image-guided robotic biopsy of brain lesions with the SurgiScope system (ISIS Intelligent Surgical Instruments & Systems). The report, which analyzes feasibility of the procedure, diagnostic yield, and safety, concludes that as the availability of image guided surgery has increased, frameless robotic stereotactic biopsy techniques have become more prevalent. To read a review of the system, click here.  

Sodium Imbalance Impacts Children with Brain Tumors Undergoing Surgery 
The Journal of Neurosurgery: Pediatrics (May 2012) published a study that assessed the incidence of and risk factors for hyponatremia (sodium imbalance) among children hospitalized for resection of a brain tumor. The research reports that hyponatremia was present in 8.7% of tumor resection cases, with the incidence increasing more than two-fold in children with tumors in deep brain structures and/or obstructive hydrocephalus. The authors suggest further research is needed to develop targeted monitoring and intervention strategies with the goal of improving surgical outcomes in children experiencing this effect. For more details on this study, click here.   
 

Fundraising Tab
5K “Day-Of” Registration
Registration for the Breakthrough for Brain Tumors Chicago 5K Run/Walk is now closed. On-site registration will be available for any last minute participants. The event will take place this Saturday, May 12, at Chicago’s Montrose Harbor. The 5K Run starts at 7:45 a.m. and the all-ages Walk starts at 8:30 a.m. "Day-of" registrants will be able to run, but will not be timed. For event day information, visit www.breakthroughforbraintumors.org.

 AboutABTA.gif
Founded in 1973, the American Brain Tumor Association (ABTA) was the first national nonprofit organization dedicated solely to brain tumor research. For nearly 40 years, the Chicago-based ABTA has been providing comprehensive resources that support the complex needs of brain tumor patients and caregivers, as well as the critical funding of research in the pursuit of breakthroughs in brain tumor diagnosis, treatment and care.

Make a donation to the American Brain Tumor Association.

This information is provided by the American Brain Tumor Association, 8550 W. Bryn Mawr Ave., Suite 550, Chicago, IL 60631. For more information about the American Brain Tumor Association, call toll-free 866-659-1030, write info@abta.org or visit www.abta.org.

 

"American Brain Tumor Association" and "TrialConnect" are registered trademarks of the American Brain Tumor Association. The ABTA logo, the "Breakthrough for Brain Tumors" name and logo, and the "Team Breakthrough" name and logo are trademarks of the American Brain Tumor Association. All rights reserved.

Update Email Preferences | Forward to a Friend | Unsubscribe
©2012 American Brain Tumor Association 
 
 

 connections_new.JPG FaceBook trialconnect_icon.JPG Twitter [object Object] 

Having Fun Raising Funds

To learn more about our events visit www.abta.org/events.

Breakthrough for Brain Tumors 5K Run/Walk
May 12, 2012
Chicago, IL

9th Annual Glio-Blastoff 5K
May 12, 2012
Ypsilanti, MI  

Joggin for the Noggin
May 12, 2012
Spokane, WA

Eric Perry Memorial Run/Walk
June 2, 2012
Los Angeles, CA

8th Annual Head for the Cure
June 9, 2012
Carmel, IN

Sharing Hope - Walk the Walk, Talk the Talk
June 9, 2012
Storrs, CT

Jerry Hoyt Memorial Cancer Walk
July 7, 2012
Windsor, NY

7th Annual Teeing Up for Others
July 20, 2012
Columbia Station, OH

Paul Fabbri Memorial Golf Classic
September 22, 2012

Breakthrough for Brain Tumors NYC 5K Run/Walk
November 10, 2012
New York, NY

Online Community
The ABTA's Connections links patients, families, friends, caregivers and health care professionals with each other for support and inspiration. The online community is a safe place to visit, join and interact with members of the brain tumor community nationally and around the world.

Find a Clinical Trial Through Trial Connect
The ABTA's TrialConnect, a free and confidential service administered by EmergingMed, is offered in English and Spanish. Read more.

Consultation Services
Our Care Consultants provide brain tumor information, support and education for patients, families and health care professionals. Write abtacares@abta.org or call our toll-free CareLine at 800-886-ABTA (2282).

 
ConnectionsHomepageNewFlash_July2011.JPG

This communication is not intended as a substitute for professional medical advice and does not provide advice on treatments or conditions for individual patients. All health and treatment decisions must be made in consultation with your physician(s), utilizing your specific medical information. The links set out on this communication are provided for your convenience only. The American Brain Tumor Association does not endorse the information contained on the linked websites or individual(s)/companies/institutions operating these websites.